4 / 27
and stroma predicts benefit
to pembrolizumab in bladder
cancer
Phase Ib multi-cohort KEYNOTE-012 basket trial:
Locally advanced or metastatic urothelial cancer
Plimack, ER et al. Lancet Oncol 2017
|
|
4 / 27
4 / 27
and stroma predicts benefit
to pembrolizumab in bladder
cancer
Phase Ib multi-cohort KEYNOTE-012 basket trial:
Locally advanced or metastatic urothelial cancer
Plimack, ER et al. Lancet Oncol 2017